Product Information
PREVALITE PACKET is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $0.8327 per EA under NDC 00245003642. Its NADAC has been published 653 times since Nov 28, 2013.
Strength
4 g/5.5g
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245003642
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CHOLESTYRAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA073263On Market Since
2/1/1996
Pharmacological Classes
Price Statistics
The NADAC for PREVALITE PACKET has been published 653 times since Nov 28, 2013, and over the history we have for it it has declined 52.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8327 per EA |
|---|---|
| All-time high | $2.1232 (Jul 15, 2015) |
| All-time low | $0.7336 (Apr 17, 2024) |
| 52-week high | $0.9006 |
| 52-week low | $0.7955 |
| Median price | $1.4150 |
| Average price | $1.4567 |
| Largest weekly change | +21.4% (Jun 19, 2024) |
| Weeks tracked | 653 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PREVALITE PACKET?
The current National Average Drug Acquisition Cost (NADAC) for PREVALITE PACKET, manufactured by Upsher-Smith Laboratories LLC, is $0.8327 per EA (NDC 00245003642), effective Jun 24, 2026.
How has the price of PREVALITE PACKET changed over time?
Over the history we have for it, the NADAC for PREVALITE PACKET has declined 52.9%. It has been tracked across 653 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PREVALITE PACKET?
Since Nov 28, 2013, the NADAC for PREVALITE PACKET has ranged from a low of $0.7336 (Apr 17, 2024) to a high of $2.1232 (Jul 15, 2015), with a median of $1.4150 per EA.
Are there cheaper alternatives to PREVALITE PACKET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CHOLESTYRAMINE PACKET, is $0.6978 per EA — about 16% below PREVALITE PACKET.
Who manufactures PREVALITE PACKET?
PREVALITE PACKET (NDC 00245003642) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification